Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells

V. Pavet (Corresponding Author), Y. Shlyakhtina, Tao He, D.G. Geschin, P. Kohonen, M. Perälä, O. Kallioniemi, H. Gronemeyer (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

14 Citations (Scopus)

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/TNFSF10/Apo2L) holds promise for cancer therapy as it induces apoptosis in a large variety of cancer cells while exerting negligible toxicity in normal ones. However, TRAIL can also induce proliferative and migratory signaling in cancer cells resistant to apoptosis induced by this cytokine. In that regard, the molecular mechanisms underlying the tumor selectivity of TRAIL and those balancing apoptosis versus survival remain largely elusive. We show here that high mRNA levels of PLAU, which encodes urokinase plasminogen activator (uPA), are characteristic of cancer cells with functional TRAIL signaling. Notably, decreasing uPA levels sensitized cancer cells to TRAIL, leading to markedly increased apoptosis. Mechanistic analyses revealed three molecular events taking place in uPA-depleted cells: reduced basal ERK1/2 prosurvival signaling, decreased preligand decoy receptor 2 (DcR2)-death receptor 5 (DR5) interaction and attenuated recruitment of DcR2 to the death-inducing signaling complex upon TRAIL challenge. These phenomena were accompanied by increased FADD and procaspase-8 recruitment and processing, thus guiding cells toward a caspase-dependent cell death that is largely independent of the intrinsic apoptosis pathway. Collectively, our results unveil PLAU mRNA levels as marker for the identification of TRAIL-responsive tumor cells and highlight a key role of uPA signaling in 'apoptosis versus survival' decision-making processes upon TRAIL challenge
Original languageEnglish
Article numbere1043
JournalCell Death and Disease
Volume5
DOIs
Publication statusPublished - 2014
MoE publication typeA1 Journal article-refereed

Fingerprint Dive into the research topics of 'Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells'. Together they form a unique fingerprint.

  • Cite this

    Pavet, V., Shlyakhtina, Y., He, T., Geschin, D. G., Kohonen, P., Perälä, M., Kallioniemi, O., & Gronemeyer, H. (2014). Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death and Disease, 5, [e1043]. https://doi.org/10.1038/cddis.2014.5